Description
Infectious Disease Conference
Saturday, April 12, 2025
COVID-19 Therapies: What Pharmacists Need to Know
8:00-9:30am C/G/T
Kathleen Jodoin, PharmD, BCPS, Pharmacy Clinical Coordinator, Mount Sinai Medical Center
Upon completion of this activity, pharmacists will be able to: Describe the pathophysiology of COVID-19; Review current guidelines and recommendations for COVID-19 management; Assess the role of pharmacists in COVID-19 prevention and management; Provide an overview of recent clinical studies, including emerging therapies for COVID-19 management. UAN: 0675-0000-25-011-L01-P*
Upon completion of this activity, technicians will be able to: Describe the progression of COVID-19; Review current guidelines and recommendations for COVID-19 management; Provide an overview of recent clinical studies, including emerging therapies for COVID-19 treatment.
UAN: 0675-0000-25-011-L01-T*
Navigating Clinical Guidelines: Best Practices for the Management of Pneumonia
9:30-11:00am C/G/T
Anthony M. Casapao, PharmD, MPH, FIDSA, Clinical Associate Professor of Pharmacy Education and Practice, University of Florida College of Pharmacy
Upon completion of this activity, pharmacists will be able to: Identify new updates in the management of pneumonia; Interpret the utilization of biomarkers and their potential use in patients with pneumonia; Describe the strengths and limitations of new antimicrobials to treat patients with pneumonia.
UAN: 0675-0000-25-012-L01-P*
Upon completion of this activity, technicians will be able to: Identify new updates in the management of pneumonia; Interpret the utilization of biomarkers and their potential use in patients with pneumonia; Describe the strengths and limitations of new antimicrobials to treat patients with pneumonia.
UAN: 0675-0000-25-012-L01-T*
Herd It All Before: The Importance of Immunizations to Public Health
11:15-12:45pm C/G/T
Calvin Tucker, PharmD, MBA, FCCM, FFSHP, Manager, Cancer Center Pharmacy, Mayo Clinic
Upon completion of this activity, pharmacists will be able to: Define the types of immunity; Explain the process of how immunizations are created; Describe the impact of immunizations on public health; Highlight the role of pharmacists in the vaccinations of patients. UAN: 0675-0000-25-013-L06-P
Upon completion of this activity, technicians will be able to: Define the types of immunity; Explain the process of how immunizations are created; Describe the impact of immunizations on public health. UAN: 0675-0000-25-013-L06-T
Pharmacologic Strategies for CDI: from first -Line Therapy to Recurrent Infections
12:45-2:15pm C/G/T
Kathleen Jodoin, PharmD, BCPS, Pharmacy Clinical Coordinator, Mount Sinai Medical Center
Upon completion of this activity, pharmacists will be able to: Describe the pathophysiology of Clostridioides difficile infection (CDI); Review the evolution of CDI management guidelines; Review current guidelines and recommendations for CDI management; Assess management strategies for severe and recurrent CDI, including new therapies. UAN: 0675-0000-25-014-L01-P
Upon completion of this activity, technicians will be able to: Define Clostridioides difficile infection (CDI); Review the evolution of CDI management guidelines; Review current guidelines and recommendations for CDI management. UAN: 0675-0000-25-014-L01-T
SUNDAY, APRIL 13, 2025
The Evolving Landscape of HIV/AIDS: Updates on Antiretroviral Therapy, PrEP, and PEP for Pharmacists
8:00-9:30am C/G/T
Elizabeth Sherman, PharmD, Associate Professor of Pharmacy Practice, Principal Investigator, NSU Local Partner Site, South Florida – Southeast AIDS Education and Training Center, Nova Southeastern University
Upon completion of this activity, pharmacists will be able to: Interpret current Florida law on HIV/AIDS and its impact on testing, reporting, confidentiality, procedures for pregnant women and partner notification; Describe the epidemiology of HIV and the importance of infection control procedures; Identify modes of HIV transmission; Discuss pharmacist opportunities in HIV prevention including pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP); Distinguish the various therapeutic agents used to treat HIV/AIDS; List complications associated with HIV/AIDS; Identify the pharmacist’s role in providing care for HIV patients. UAN: 0675-0000-25-015-L02-P
Upon completion of this activity, technicians will be able to: Identify methods of transmission of HIV/AIDS; List medication agents used to treat HIV/AIDS; Recognize the importance of compliance and the results of opportunistic infections which may occur in patients; Identify ways the technician can provide care for HIV infected patients; Explain current Florida law on HIV/AIDS and its impact on testing, reporting and partner notification; Identify HIV preventive measures including pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP). UAN: 0675-0000-25-015-L02-T
Sexually Transmitted Infections: A Pharmacist’s Guide to Prevention, Screening, and Treatment
9:30-11:00am C/G/T
Elias B. Chahine, PharmD, FCCP, FASCP, FFSHP, BCIDP, Professor and Chair of Pharmacy Practice, Gregory School of Pharmacy, Palm Beach Atlantic University
Upon completion of this activity, pharmacists will be able to: Identify recent epidemiological trends of sexually transmitted infections; Describe the 5 “Ps” approach to interviewing patients about sexually transmitted infections; Determine appropriate screening criteria for chlamydia, gonorrhea, and syphilis; Identify the most common etiologies of sexually transmitted infections; Recognize signs and symptoms of common sexually transmitted infections; Given patient-specific information, design the most appropriate antimicrobial regimen for the treatment of each discussed sexually transmitted infection; Devise strategies to prevent sexually transmitted infections. UAN: 0675-0000-25-016-L01-P*
Upon completion of this activity, technicians will be able to: Identify recent epidemiological trends of sexually transmitted infections; Describe the 5 “Ps” approach to interviewing patients about sexually transmitted infections; Determine appropriate screening criteria for chlamydia, gonorrhea, and syphilis; Identify the most common etiologies of sexually transmitted infections; Recognize signs and symptoms of common sexually transmitted infections; Given patient-specific information, recognize the most appropriate treatment of each discussed sexually transmitted infection; Devise strategies to prevent sexually transmitted infections. UAN: 0675-0000-25-016-L01-T
Decoding Resistance: A Pharmacist's Guide to Multi-Drug Resistant Pathogens
11:15-12:45pm C/G/T
Tony Anderson, PharmD, BCPS, BCIDP, Clinical Pharmacist – Immunocompromised Infectious Diseases/Antimicrobial Stewardship, Sylvester Comprehensive Cancer Center, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine
Upon completion of this activity, pharmacists will be able to: Define Multidrug-Resistant Organisms (MDRO) and identify the most common pathogens; Describe the mechanisms behind multi-drug resistance (MDR); Compare available antimicrobial agents for MDR pathogens; Evaluate the impact of MDR on patient care and public health. UAN: 0675-0000-25-017-L01-P*
Upon completion of this activity, technicians will be able to: Define Multidrug-Resistant Organisms (MDRO) and identify the most common pathogens; Explain the rationale behind multi-drug resistance (MDR); Compare available antimicrobial agents for MDR pathogens; Evaluate the impact of MDR on patient care and public health. UAN: 0675-0000-25-017-L01-T*
Pharmacists as Stewards: Strategies for Effective Antimicrobial Stewardship
12:45-2:15pm C/G/T
Elias B. Chahine, PharmD, FCCP, FASCP, FFSHP, BCIDP, Professor and Chair of Pharmacy Practice, Gregory School of Pharmacy, Palm Beach Atlantic University
Upon completion of this activity, pharmacists will be able to: Explore the threat of antimicrobial resistance on health systems and patient outcomes; Classify antibiotic-resistant organisms according to the CDC threat levels; Identify the four objectives of an antimicrobial stewardship program; Identify the CDC core elements of hospital, outpatient, and nursing home antimicrobial stewardship programs; Describe the role of pharmacists and available training opportunities in antimicrobial stewardship; Provide recommendations for implementing an effective antimicrobial stewardship program. UAN: 0675-0000-25-018-L01-P*
Upon completion of this activity, technicians will be able to: Assess the threat of antimicrobial resistance on health systems and patient outcomes; Classify antibiotic-resistant organisms according to the CDC threat levels; Identify the four objectives of an antimicrobial stewardship program; Provide recommendations for implementing an effective antimicrobial stewardship program.
UAN: 0675-0000-25-018-L01-T*
C = Consultant CPE G = General Pharmacist
